Current concepts and issues in blood management

Orthopedics

Volumn 27, Issue 6 SUPPL., 2004, Pages

  Spence, Richard K ^a  

^a St Agnes HealthCare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDOSIS; ALLERGIC URTICARIA; ANAPHYLAXIS; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DISEASE TRANSMISSION; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKALEMIA; HYPOTENSION; HYPOTHERMIA; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RISK; INTERMETHOD COMPARISON; ORTHOPEDIC SURGERY; PARASITOSIS; PURPURA; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT PLANNING; VIRUS INFECTION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; ORTHOPEDIC PROCEDURES; RISK; TRANSPLANTATION IMMUNOLOGY;

EID: 3142764851     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Sugarman J, Harland R. Acute yet non-emergent patients. In: Surgical Ethics. New York, NY. Oxford University Press; 1998:116-132.
2. Williamson L, Cohen H, Love E, Jones H, Todd A, Soldan K. The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance. Vox Sang. 2000; 78:291-295.
3. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev. 1999; 13:177-186.
4. Linden J, Pau B, Dressler K. A report of 104 transfusion errors in New York State. Transfusion. 1992; 32:601-606.
5. Linden JV. Errors in transfusion medicine: scope of the problem. Arch Pathol Lab Med. 1999; 123:563-565.
6. Mercuriali F. Bedside transfusion errors: analysis of 2 years' use of a system to monitor and prevent transfusion errors. Vox Sang. 1996; 70:16-20.
7. McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products: an underrecognized transfusion reaction. Am J Clin Pathol. 1999; 111:202-206.
8. Davenport R. Management of transfusion reactions. In: Transfusion Therapy: Clinical Principles and Practice. Bethesda, MD: AABB Press; 1999:359-378.
9. Bluemle LJ. Hemolytic transfusion reactions causing acute renal failure: serologic and clinical considerations. Postgrad Med. 1965; 30:583-590.
10. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion. 1990; 30:583-588.
11. Haverly RM, Harrison CR, Dougherty TH. Yersinia enterocolitica bacteremia associated with red blood cell transfusion. Arch Pathol Lab Med. 1996; 120:499-500.
12. Burstain JM. Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolism. Transfusion. 1997; 37:255-258.
13. Haditsch M. Yersinia enterocolitica septicemia in autologous blood transfusion. Transfusion. 1994; 10:907-909.
14. Dry SM. The pathology of transfusion-related acute lung injury. Am J Clin Pathol. 1999; 112:216-221.
15. Densmore TL. Prevalence of HLA sensitization in female apheresis donors. Transfusion. 1999; 39:103-106.
16. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003; 101:454-462.
17. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev. 2003; 17:252-262.
18. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther. 2002; 9:389-395.
19. Update: Detection of West Nile virus in blood donations-United States, 2003. Morb Mortal Wkly Rep. 2003; 2:916-919.
20. Cerhan JR, Wallace RB, Dick F, et al. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2001; 10:361-368.
21. Vamvakas EC. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion. 2003; 43:963-973.
22. Ghio M, Contini P, Mazzei C, et al. Soluble HLA class I and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions. Leuk Lymphoma. 2000; 39:29-36.
23. Creteur J, Vincent JL. Hemoglobin solutions. Crit Care Med. 2003; 31:S698-S707.
24. Shander A. Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol. 2004; 41:117-124.
25. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002; 30:2249-5224.
26. Nelson JL. Microchimerism in human health and disease. Autoimmunity. 2003; 36:5-9.
27. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood. 1999; 93:3127-3139.
28. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 1993; 269:3024-3029.
29. Hebert PC. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340:409-417.
30. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest. 1995; 108:767-71.
31. Carson JL. Perioperative blood transfusion and postoperative mortality. JAMA. 1998; 279:199-205.
32. Shoemaker WC, Wo CC. Circulatory effects of whole blood, packed red cells, albumin, starch, and crystalloids in resuscitation of shock and acute critical illness. Vox Sang. 1998; 74:69-74.
33. Bickell WH. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994; 331:1105-1109.
34. Spence RK. Transfusion and surgery. Curr Probl Surg. 1993; 30:1101-1180.
35. Wittmann PH, Wittmann FW. Total hip replacement surgery without blood transfusion in Jehovah's Witnesses. Br J Anaesth. 1992; 68:306-307.
36. Carson JL. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996; 348:1055-1060.
37. Spiess B. Autologous blood donation: hemodynamics in a high-risk patient population. Transfusion. 1992; 32:17-22.
38. Goodnough LT. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med. 1999; 340:438-447.
39. Goodnough LT, Verbrugge D, Marcus RE. The relationship between hematocrit, blood lost, and blood transfused in total knee replacement: implications for postoperative blood salvage and reinfusion. Am J Knee Surg. 1995; 8:83-87.
40. Dzik W. Blood salvage: washed versus non-washed. In: Autotransfusion: Therapeutic Principles and Trends. Detroit, MI: Gregory Appleton; 1997:319-328.
41. Spence RK. Surgical red blood cell transfusion practice policies. Am J Surg. 1995; 170:3S-15S.
42. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who receive blood transfusion. Transfusion. 2002; 42:812-818.
43. Slappendel R, Dirksen R, Weber EW, van der Schaaf DB. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand. 2003; 74:569-575.
44. Graham ID, Alvarez G, Tetroe J, McAuley L, Laupacis A. Factors influencing the adoption of blood alternatives to minimize allogeneic transfusion: the perspective of eight Ontario hospitals. Can J Surg. 2002; 45:132-140.
45. Keating EM, Meding JB. Perioperative blood management practices in elective orthopaedic surgery. Am Acad Orthop Surg. 2002; 10:393-400.
46. Earnshaw P. Blood conservation in orthopaedic surgery: the role of epoetin alfa. Int Orthop. 2001; 25:273-278.
47. Lofthouse RA, Boitano MA, Davis JR, Jinnah RH. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction. J South Orthop Assoc. 2000; 9:175-181.
48. Henry DH, Bowers P, Romano MT, Provenzano R. Epoetin alfa: clinical evolution of a pleiotropic cytokine. Arch Intern Med. 2004; 164:262-276.
49. Goodnough LT, Price TH, Rudnick S, Soegiarso RW. Preoperative red blood cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion. 1992; 32:441-445.
50. Goldman M, Savard R, Long A, Gelinas S, Germain M. Declining value of preoperative autologous donation. Transfusion. 2002; 42:819-823.
51. Forgie M, Wells P, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red cell transfusion: results of a meta analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med. 1998; 158:610-616.
52. Schmied H, Schiferer A, Sessler DI, Meznik C. The effects of red-cell scavenging, hemodilution, and active warming on allogenic blood requirements in patients undergoing hip or knee arthroplasty. Anesth Analg. 1998; 86:387-391.
53. Goodnough LT, Monk TG, Brecher ME. Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurement. Transfusion. 1998; 38:473-476.
54. Warner C. The use of the orthopaedic perioperative autotransfusion (OrthoPAT) system in total joint replacement surgery. Orthop Nurs. 2001; 20:29-32.
55. Huet C, Salmi LR, Fergusson D, et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg. 1999; 89:861-869.
56. Benli IT, Akalin S, Duman E, Citak M, Kis M. The results of intraoperative autotransfusion in orthopaedic surgery. Bull Hosp Jt Dis. 1999; 58:184-187.
57. Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion. 2003; 43:668-676.
58. Velanovich V, Weaver M. Partial splenectomy using a coupled saline-radiofrequency hemostatic device. Am J Surg. 2003; 1:185.
59. Braswell C, Campos J, Spence RK. Reducing operative blood loss during hepatic surgery: from the middle ages to the space age. Current Surgery. 2001; 58:472-477.
60. Fasulo F. Cavition Ultrasonic Surgical Aspirator (CUSA) in liver resection. Int Surg. 1992; 77:64-66.
61. Une Y. Water jet scalpel for liver resection in hepatocellular carcinoma with or without cirrhosis. Int Surg. 1996; 81:45-48.
62. Wang GJ, Hungerford DS, Savory CG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001; 83:1503-1505.